NasdaqGS - Delayed Quote USD

Alector, Inc. (ALEC)

1.4100
-0.1400
(-9.03%)
At close: June 5 at 4:00:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
88,339
100,558
97,062
133,617
207,085
Operating Expense
234,323
245,555
248,802
271,451
244,445
Operating Income
-145,984
-144,997
-151,740
-137,834
-37,360
Other Income Expense
22,664
26,076
26,561
7,778
1,031
Pretax Income
-123,320
-118,921
-125,179
-130,056
-36,329
Tax Provision
121
128
5,212
3,254
0
Net Income Common Stockholders
-123,441
-119,049
-130,391
-133,310
-36,329
Diluted NI Available to Com Stockholders
-123,441
-119,049
-130,391
-133,310
-36,329
Basic EPS
-1.26
-1.23
-1.56
-1.62
-0.45
Diluted EPS
-1.26
-1.23
-1.56
-1.62
-0.45
Basic Average Shares
97,985.1830
96,588.1770
83,733.7300
82,467.5870
80,416.9360
Diluted Average Shares
97,985.1830
96,588.1770
83,733.7300
82,467.5870
80,416.9360
Total Operating Income as Reported
-145,984
-144,997
-151,740
-137,834
-37,360
Total Expenses
234,323
245,555
248,802
271,451
244,445
Net Income from Continuing & Discontinued Operation
-123,441
-119,049
-130,391
-133,310
-36,329
Normalized Income
-123,441
-119,049
-130,391
-133,310
-36,329
EBIT
-145,984
-144,997
-151,740
-137,834
-37,360
EBITDA
-137,586
-136,156
-142,892
-129,362
-29,045
Reconciled Depreciation
8,398
8,841
8,848
8,472
8,315
Net Income from Continuing Operation Net Minority Interest
-123,441
-119,049
-130,391
-133,310
-36,329
Normalized EBITDA
-137,586
-136,156
-142,892
-129,362
-29,045
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 2/7/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DNLI Denali Therapeutics Inc.
14.22
-1.39%
 
STOK Stoke Therapeutics, Inc.
10.88
-0.55%
 
PASG Passage Bio, Inc.
0.4500
-6.83%
 
GOSS Gossamer Bio, Inc.
1.2600
0.00%
 
OLMA Olema Pharmaceuticals, Inc.
4.2100
-0.24%
 
STRO Sutro Biopharma, Inc.
0.8243
-9.36%
 
BDTX Black Diamond Therapeutics, Inc.
2.4900
-1.97%
 
ENTA Enanta Pharmaceuticals, Inc.
7.21
+1.41%
 
CGEM Cullinan Therapeutics, Inc.
8.74
-3.64%
 
TCRX TScan Therapeutics, Inc.
1.6800
-5.62%